Version
A Proteogenomic Gene Signature Defines Prognostic Subgroups Highlighting PI3K/AKT/mTOR Signaling Pathway as a Therapeutic Vulnerability in Myeloid Malignancies
CTSA https://pubmed.ncbi.nlm.nih.gov/41402890/ 2025-12-16T00:00:00Z Cell Communication and Signaling
Citation Text
A Proteogenomic Gene Signature Defines Prognostic Subgroups Highlighting PI3K/AKT/mTOR Signaling Pathway as a Therapeutic Vulnerability in Myeloid Malignancies